Platelet and Soluble CD40L in Meningococcal Sepsis

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2006 Jul 1

PMID 16810523

Citations 14

Authors

David P Inwald

Saul N Faust

Paula Lister

Mark J Peters

Michael Levin

Robert Heyderman

Nigel J Klein

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the influence of meningococcal sepsis on levels of platelet derived CD40L and on endothelial CD40 expression.

Design And Setting: Prospective observational study in two tertiary paediatric intensive care units.

Patients And Participants: 63 children with meningococcal sepsis and 10 age-matched controls.

Measurements And Results: (a) sCD40L ELISA of plasma from patients with meningococcal sepsis (n = 49) and age matched controls (n = 10). This demonstrated higher sCD40L levels in patients (median 0.29 ng/ml, IQR 0.2-0.41) than controls (0.09 ng/ml, 0.08-0.12). However, there was no relationship between plasma sCD40L level and platelet count or disease severity. (b) Flow cytometry of fresh blood from patients with meningococcal sepsis (n = 11) and age-matched controls (n = 10) for membrane bound CD40L and CD62P on circulating platelets. This demonstrated low levels of CD40L and CD62P in patients and controls. CD40L+ platelets were 3.5% (3.0-4.8) in patients and 4.9% (3.5-4.3) in controls. CD62P+ platelets were 10.7% (6.4-12.8) in patients and 7.9% (5.9-13.0) in controls. (c) Immunohistochemistry of skin biopsy specimens from six patients, staining for endothelial CD40 expression at sites of microthrombus formation, which demonstrated preserved CD40 expression in vascular endothelium at sites of microthrombus formation.

Conclusions: The elevated sCD40L level in meningococcal sepsis implies release of sCD40L from platelets. However, there was no relationship between plasma sCD40L level and the degree of thrombocytopenia or disease severity. Furthermore, platelet surface bound CD40L was similar in controls and patients. Thus, further investigation is needed to determine whether platelet CD40L contributes to inflammation and thrombosis in MCS.

Citing Articles

Blood Platelets in Infection: The Multiple Roles of the Platelet Signalling Machinery.

Trivigno S, Guidetti G, Barbieri S, Zara M Int J Mol Sci. 2023; 24(8).

PMID: 37108623 PMC: 10138547. DOI: 10.3390/ijms24087462.

Systemic inflammatory markers of persistent cerebral edema after aneurysmal subarachnoid hemorrhage.

Ahn S, Burkett A, Paz A, Savarraj J, Hinds S, Hergenroeder G J Neuroinflammation. 2022; 19(1):199.

PMID: 35927663 PMC: 9354324. DOI: 10.1186/s12974-022-02564-1.

An Insight into Recent Advances on Platelet Function in Health and Disease.

Chaudhary P, Kim S, Kim S Int J Mol Sci. 2022; 23(11).

PMID: 35682700 PMC: 9181192. DOI: 10.3390/ijms23116022.

Platelets as Key Factors in Inflammation: Focus on CD40L/CD40.

Cognasse F, Duchez A, Audoux E, Ebermeyer T, Arthaud C, Prier A Front Immunol. 2022; 13:825892.

PMID: 35185916 PMC: 8850464. DOI: 10.3389/fimmu.2022.825892.

Persistently higher serum sCD40L levels are associated with outcome in septic patients.

Liang Y, Zhu C, Sun Y, Li Z, Wang L, Liu Y BMC Anesthesiol. 2021; 21(1):26.

PMID: 33482737 PMC: 7820820. DOI: 10.1186/s12871-021-01241-9.

References

McEver R . Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost. 2001; 86(3):746-56. View

Hawrylowicz C, Howells G, Feldmann M . Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med. 1991; 174(4):785-90. PMC: 2118954. DOI: 10.1084/jem.174.4.785. View

Kotowicz K, Dixon G, Klein N, Peters M, Callard R . Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology. 2000; 100(4):441-8. PMC: 2327040. DOI: 10.1046/j.1365-2567.2000.00061.x. View

Prasad K, Andre P, He M, Bao M, Manganello J, Phillips D . Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci U S A. 2003; 100(21):12367-71. PMC: 218764. DOI: 10.1073/pnas.2032886100. View

Stenberg P, McEver R, Shuman M, Jacques Y, BAINTON D . A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985; 101(3):880-6. PMC: 2113718. DOI: 10.1083/jcb.101.3.880. View

Faust S, Levin M, Harrison O, Goldin R, Lockhart M, Kondaveeti S . Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001; 345(6):408-16. DOI: 10.1056/NEJM200108093450603. View

Ahn E, Lander G, Jy W, Bidot C, Jimenez J, Horstman L . Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res. 2004; 114(2):143-8. DOI: 10.1016/j.thromres.2004.06.005. View

Heeschen C, Dimmeler S, Hamm C, van den Brand M, Boersma E, Zeiher A . Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003; 348(12):1104-11. DOI: 10.1056/NEJMoa022600. View

Karmann K, Hughes C, Schechner J, Fanslow W, Pober J . CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A. 1995; 92(10):4342-6. PMC: 41940. DOI: 10.1073/pnas.92.10.4342. View

10.

Kato K, Rassenti L, Weisman M, Tamura N, Kobayashi S, Hashimoto H . The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest. 1999; 104(7):947-55. PMC: 408556. DOI: 10.1172/JCI7014. View

11.

Pollack M, Patel K, Ruttimann U . PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996; 24(5):743-52. DOI: 10.1097/00003246-199605000-00004. View

12.

Lindmark E, Tenno T, Siegbahn A . Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol. 2000; 20(10):2322-8. DOI: 10.1161/01.atv.20.10.2322. View

13.

Inwald D, Peters M, Walshe D, Jones A, Davies E, Klein N . Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome. Clin Exp Immunol. 2000; 120(3):499-502. PMC: 1905570. DOI: 10.1046/j.1365-2249.2000.01235.x. View

14.

Henn V, Slupsky J, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G . CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998; 391(6667):591-4. DOI: 10.1038/35393. View

15.

Peters M, Heyderman R, Faust S, Dixon G, Inwald D, Klein N . Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet-neutrophil complexes. J Leukoc Biol. 2003; 73(6):722-30. DOI: 10.1189/jlb.1002509. View

16.

Tanaka T, Kuroiwa T, Ikeuchi H, Ota F, Kaneko Y, Ueki K . Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury. J Am Soc Nephrol. 2002; 13(10):2488-96. DOI: 10.1097/01.asn.0000029588.07166.20. View

17.

Scott M, Hoth J, Stagner M, GARDNER S, Peyton J, Cheadle W . CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent. Clin Exp Immunol. 2004; 137(3):469-77. PMC: 1809143. DOI: 10.1111/j.1365-2249.2004.02547.x. View

18.

Inwald D, McDowall A, Peters M, Callard R, Klein N . CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res. 2003; 92(9):1041-8. DOI: 10.1161/01.RES.0000070111.98158.6C. View

19.

Andre P, Nannizzi-Alaimo L, Prasad S, Phillips D . Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation. 2002; 106(8):896-9. DOI: 10.1161/01.cir.0000028962.04520.01. View

20.

Inwald D, Kirkham F, Peters M, Lane R, Wade A, Evans J . Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol. 2000; 111(2):474-81. DOI: 10.1046/j.1365-2141.2000.02353.x. View